Evaluation of thermal stability of indinavir sulphate using diffuse reflectance infrared spectroscopy

  • Singh P
  • Premkumar L
  • Mehrotra R
 et al. 
  • 4


    Mendeley users who have this article in their library.
  • 11


    Citations of this article.


Indinavir sulphate is a potent and specific protease inhibitor of human immunodeficiency virus (HIV). It is used for the treatment of acquired immune deficiency syndrome (AIDS). At elevated temperature the drug which otherwise remains crystalline undergoes a phase transition to an amorphous phase to form degradation products. In the present study, thermal stability of indinavir sulphate is evaluated using diffuse reflectance infrared Fourier transform (DRIFT) spectroscopy. Infrared spectra of the drug before and after the exposure to thermal radiation at different temperatures were acquired in the diffuse reflectance mode using a Fourier transform infrared (FTIR) spectrophotometer. The differential scanning calorimetry (DSC) and the X-ray diffraction (XRD) studies were used as complimentary techniques to adequately implement and assist the interpretation of the infrared spectroscopy results. The DRIFT spectra reveal that the drug remains stable up to 100 °C, degrades slightly at 125 °C and undergoes complete degradation at about 150 °C to produce degradation products. The degradation products can easily be characterized using the infrared spectra. © 2008 Elsevier B.V. All rights reserved.

Author-supplied keywords

  • Diffuse reflectance
  • HIV protease inhibitors
  • ICH
  • Indinavir sulphate
  • Infrared spectroscopy
  • Thermal stability

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • Parul Singh

  • L. Premkumar

  • Ranjana Mehrotra

  • H. C. Kandpal

  • A. K. Bakhshi

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free